Stock ASG AURORA SPINE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Aurora Spine Corporation

Equities

ASG

CA05206X1087

Medical Equipment, Supplies & Distribution

Market Closed - Toronto S.E.
Other stock markets
 02:59:42 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.29 CAD +5.45% Intraday chart for Aurora Spine Corporation -3.33% -27.50%
Mar. 20 Aurora Spine on 2nd Anniversary of Implantation of First Bone Density Matched DEXA-C Cervical Interbody Fusion Device MT
Feb. 05 Aurora Spine's Second Patent Related To DEXA Technology Patient-Matched Implant Technology Issued by U.S. Patent Office MT

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 2.586 12.47 10.01 17.4 18.21 22.39
Enterprise Value (EV) 1 4.475 13.63 12.1 18.16 17.58 24.94
P/E ratio -1.12 x -170 x -7.98 x -73.9 x -6.79 x -14.9 x
Yield - - - - - -
Capitalization / Revenue 0.43 x 1.44 x 0.9 x 2.01 x 1.73 x 1.51 x
EV / Revenue 0.75 x 1.57 x 1.09 x 2.1 x 1.67 x 1.68 x
EV / EBITDA -4.71 x 15.6 x -15 x -26.5 x -8.56 x -33.6 x
EV / FCF -14.7 x 675 x 302 x -18.3 x -7.17 x -11.9 x
FCF Yield -6.8% 0.15% 0.33% -5.46% -14% -8.4%
Price to Book 1.57 x 4.31 x 5.66 x 5.31 x 3.27 x 5.21 x
Nbr of stocks (in thousands) 36,169 45,434 46,478 55,410 66,731 66,731
Reference price 2 0.0715 0.2746 0.2154 0.3140 0.2729 0.3356
Announcement Date 4/27/18 4/26/19 6/4/20 4/30/21 4/29/22 4/28/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 5.989 8.682 11.15 8.646 10.54 14.88
EBITDA 1 -0.9499 0.872 -0.8052 -0.6862 -2.054 -0.7412
EBIT 1 -1.776 0.0914 -1.079 -1.163 -2.55 -1.343
Operating Margin -29.65% 1.05% -9.68% -13.46% -24.19% -9.03%
Earnings before Tax (EBT) 1 -2.24 -0.0682 -1.254 -0.2321 -2.359 -1.501
Net income 1 -2.24 -0.0682 -1.254 -0.2321 -2.359 -1.501
Net margin -37.41% -0.79% -11.25% -2.68% -22.37% -10.09%
EPS 2 -0.0637 -0.001617 -0.0270 -0.004247 -0.0402 -0.0225
Free Cash Flow 1 -0.3042 0.0202 0.0401 -0.9918 -2.453 -2.096
FCF margin -5.08% 0.23% 0.36% -11.47% -23.26% -14.09%
FCF Conversion (EBITDA) - 2.32% - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/27/18 4/26/19 6/4/20 4/30/21 4/29/22 4/28/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 1.89 1.16 2.09 0.76 - 2.55
Net Cash position 1 - - - - 0.63 -
Leverage (Debt/EBITDA) -1.989 x 1.33 x -2.599 x -1.103 x - -3.437 x
Free Cash Flow 1 -0.3 0.02 0.04 -0.99 -2.45 -2.1
ROE (net income / shareholders' equity) -87.5% -2.96% -53.1% -9.19% -53.3% -30.4%
ROA (Net income/ Total Assets) -18% 0.94% -9.98% -10.5% -18% -8.12%
Assets 1 12.44 -7.239 12.56 2.207 13.11 18.5
Book Value Per Share 2 0.0500 0.0600 0.0400 0.0600 0.0800 0.0600
Cash Flow per Share 2 0 0.0200 0.0100 0.0300 0.0500 0.0100
Capex 1 0.06 0.29 0.29 0.51 0.72 0.77
Capex / Sales 0.94% 3.37% 2.57% 5.9% 6.83% 5.18%
Announcement Date 4/27/18 4/26/19 6/4/20 4/30/21 4/29/22 4/28/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
AURORA SPINE CORPORATION Stock Aurora Spine Corporation
-27.50% 16.28M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ASG Stock
  4. Financials Aurora Spine Corporation